Robbie Marcus
Stock Analyst at J.P. Morgan
(4.34)
# 1,334
Out of 4,690 analysts
532
Total ratings
52.8%
Success rate
7.7%
Average return
Main Sectors:
Stocks Rated by Robbie Marcus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Maintained: Hold | $86 | $91.23 | -5.73% | 26 | Aug 20, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintained: Hold | $95 → $117 | $100.91 | +15.94% | 18 | Aug 17, 2026 | |
| HTFL HeartFlow | Maintained: Buy | $35 → $45 | $47.78 | -5.82% | 6 | Aug 14, 2026 | |
| MOBI Mobia Medical | Maintained: Buy | $15 → $17 | $11.34 | +49.91% | 2 | Aug 12, 2026 | |
| BDX Becton, Dickinson and Company | Maintained: Hold | $190 → $188 | $189.52 | -0.80% | 14 | Aug 10, 2026 | |
| ENOV Enovis | Maintained: Hold | $33 → $28 | $24.90 | +12.45% | 6 | Aug 10, 2026 | |
| KMTS Kestra Medical Technologies | Initiated Coverage: Buy | $30 | $25.64 | +17.00% | 1 | Aug 10, 2026 | |
| BAX Baxter International | Maintained: Hold | $19 → $26 | $26.13 | -0.50% | 24 | Aug 6, 2026 | |
| RXST RxSight | Maintained: Sell | $9 → $6 | $7.05 | -14.89% | 19 | Aug 6, 2026 | |
| PODD Insulet | Downgraded: Hold | $275 → $152 | $145.13 | +4.73% | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $82 | $90.82 | -9.71% | 27 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $11 → $17 | $16.89 | +0.65% | 21 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 | $90.49 | +4.98% | 6 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $350 | $330.69 | +5.84% | 19 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $54 → $60 | $61.44 | -2.34% | 21 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $56 | $46.84 | +19.56% | 28 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $40 → $45 | $49.98 | -9.96% | 20 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $65 → $70 | $71.73 | -2.41% | 5 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $105 | $90.21 | +16.40% | 25 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $450 | $372.60 | +20.77% | 20 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110 → $120 | $112.47 | +6.70% | 18 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $80 → $71 | $71.17 | -0.24% | 20 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $6 | $2.95 | +103.39% | 16 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $275 → $370 | $321.68 | +15.02% | 25 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $17 | $23.73 | -28.36% | 5 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $16 | $17.15 | -6.71% | 13 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $9 → $7 | $5.50 | n/a | 27 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $7 | $13.84 | n/a | 8 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $51 | $48.54 | n/a | 20 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 → $14 | $14.41 | n/a | 10 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $8 | $4.65 | n/a | 7 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $80 → $85 | $179.87 | n/a | 13 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $95 | $120.25 | n/a | 14 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $88.43 | n/a | 1 | May 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 | $17.36 | n/a | 1 | Jun 8, 2018 |
Medtronic
Aug 20, 2026
Maintained: Hold
Price Target: $86
Current: $91.23
Upside: -5.73%
Zimmer Biomet Holdings
Aug 17, 2026
Maintained: Hold
Price Target: $95 → $117
Current: $100.91
Upside: +15.94%
HeartFlow
Aug 14, 2026
Maintained: Buy
Price Target: $35 → $45
Current: $47.78
Upside: -5.82%
Mobia Medical
Aug 12, 2026
Maintained: Buy
Price Target: $15 → $17
Current: $11.34
Upside: +49.91%
Becton, Dickinson and Company
Aug 10, 2026
Maintained: Hold
Price Target: $190 → $188
Current: $189.52
Upside: -0.80%
Enovis
Aug 10, 2026
Maintained: Hold
Price Target: $33 → $28
Current: $24.90
Upside: +12.45%
Kestra Medical Technologies
Aug 10, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $25.64
Upside: +17.00%
Baxter International
Aug 6, 2026
Maintained: Hold
Price Target: $19 → $26
Current: $26.13
Upside: -0.50%
RxSight
Aug 6, 2026
Maintained: Sell
Price Target: $9 → $6
Current: $7.05
Upside: -14.89%
Insulet
Aug 5, 2026
Downgraded: Hold
Price Target: $275 → $152
Current: $145.13
Upside: +4.73%
Aug 4, 2026
Maintained: Hold
Price Target: $82
Current: $90.82
Upside: -9.71%
Aug 4, 2026
Maintained: Sell
Price Target: $11 → $17
Current: $16.89
Upside: +0.65%
Aug 4, 2026
Maintained: Buy
Price Target: $95
Current: $90.49
Upside: +4.98%
Aug 4, 2026
Maintained: Buy
Price Target: $350
Current: $330.69
Upside: +5.84%
Aug 4, 2026
Maintained: Hold
Price Target: $54 → $60
Current: $61.44
Upside: -2.34%
Jul 30, 2026
Rated: Buy
Price Target: $56
Current: $46.84
Upside: +19.56%
Jul 30, 2026
Rated: Hold
Price Target: $40 → $45
Current: $49.98
Upside: -9.96%
Jul 30, 2026
Rated: Hold
Price Target: $65 → $70
Current: $71.73
Upside: -2.41%
Jul 28, 2026
Maintained: Buy
Price Target: $105
Current: $90.21
Upside: +16.40%
Jul 21, 2026
Maintained: Buy
Price Target: $450
Current: $372.60
Upside: +20.77%
Jul 17, 2026
Maintained: Buy
Price Target: $110 → $120
Current: $112.47
Upside: +6.70%
Jun 5, 2026
Maintained: Hold
Price Target: $80 → $71
Current: $71.17
Upside: -0.24%
May 12, 2026
Reiterated: Sell
Price Target: $6
Current: $2.95
Upside: +103.39%
Dec 18, 2025
Upgraded: Buy
Price Target: $275 → $370
Current: $321.68
Upside: +15.02%
Nov 5, 2025
Maintained: Buy
Price Target: $21 → $17
Current: $23.73
Upside: -28.36%
Oct 30, 2025
Maintained: Hold
Price Target: $13 → $16
Current: $17.15
Upside: -6.71%
Aug 8, 2025
Maintained: Sell
Price Target: $9 → $7
Current: $5.50
Upside: n/a
May 6, 2025
Maintained: Hold
Price Target: $13 → $7
Current: $13.84
Upside: n/a
Feb 11, 2025
Maintained: Buy
Price Target: $40 → $51
Current: $48.54
Upside: n/a
Dec 17, 2024
Initiated Coverage: Buy
Price Target: $9 → $14
Current: $14.41
Upside: n/a
May 8, 2024
Downgraded: Hold
Price Target: $15 → $8
Current: $4.65
Upside: n/a
May 6, 2021
Maintained: Sell
Price Target: $80 → $85
Current: $179.87
Upside: n/a
Apr 12, 2021
Downgraded: Hold
Price Target: $95
Current: $120.25
Upside: n/a
May 28, 2019
Initiated Coverage: Buy
Price Target: $34
Current: $88.43
Upside: n/a
Jun 8, 2018
Upgraded: Buy
Price Target: $40
Current: $17.36
Upside: n/a